lithium has been researched along with liraglutide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, P; Hölscher, C; Li, DF; Tian, MJ; Wang, RF; Xue, GF; Zheng, JY | 1 |
| Barichello, T; Chaves Filho, AJM; Cunha, NL; de Lucena, D; de Queiroz, T; de Souza, AG; Jucá, PM; Macedo, DS; Oliveira, JVS; Quevedo, J; Soares, MV; Valvassori, SS | 1 |
| Altun, A; Çiçekli, MN; Günaydın, C; Tiryaki, ES | 1 |
3 other study(ies) available for lithium and liraglutide
| Article | Year |
|---|---|
Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus.
Topics: Animals; Anti-Inflammatory Agents; bcl-2-Associated X Protein; Blood Glucose; Convulsants; Cytokines; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Inflammation; Liraglutide; Lithium; Male; Mitochondria; Nerve Tissue Proteins; Pilocarpine; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Status Epilepticus; Time Factors | 2018 |
The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder.
Topics: Animals; Bipolar Disorder; Dextroamphetamine; Drug Synergism; Glucagon-Like Peptide-1 Receptor; Lipid Peroxidation; Liraglutide; Lithium; Male; Mania; Memory Disorders; Mice | 2020 |
GLP-1 agonist liraglutide improves ouabain-induced mania and depressive state
Topics: Animals; Antioxidants; Glucagon-Like Peptide 1; Glutathione; Glycogen Synthase Kinase 3 beta; Liraglutide; Lithium; Mania; Ouabain; Oxidants; Rats; Sucrose; Valproic Acid | 2022 |